Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aldai is an early-stage biotechnology company focused on integrating generative artificial intelligence with high-throughput biology to accelerate drug discovery. Founded by veterans from leading AI-biotech firms such as Recursion, Insitro, and Genentech, the company aims to build a closed-loop system where machine learning models design biological experiments and the resulting data refines the models. Their approach focuses on mapping complex biological landscapes to identify novel therapeutic candidates across multiple modalities. Aldai operates primarily in stealth mode, building out its foundational technology stack and laboratory infrastructure in the San Francisco Bay Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALDAI.